ECRM_1170x120

Healthcare Distribution Management Association

HDMA updates brand identity

COLORADO SPRINGS, Colo. — The Healthcare Distribution Management Association (HDMA) has changed its name to the Healthcare Distribution Alliance (HDA). HDA president and chief executive officer John Gray announced the change at the opening general session of the association’s 2016 Business and Leadership Conference here in June. Additionally, HDA’s nonprofit charitable research foundation, the Center

In name change, HDMA becomes HDA

In name change, HDMA becomes HDA

COLORADO SPRINGS, Colo. — The Healthcare Distribution Management Association (HDMA) has changed its name to the Healthcare Distribution Alliance (HDA). John Gray, president and chief executive officer of HDA, which represents the nation’s primary pharmaceutical distributors, announced the organization’s new identity on Monday at its 2016 Business and Leadership Conference in Colorado Springs. With the

Enactment of drug abuse bill praised by Rx groups

WASHINGTON — Enactment of a new law designed to curtail drug abuse while maintaining legitimate access to medications has been hailed by pharmacy groups including the National Association of Chain Drug Stores. The legislation — which advances collaboration among health and enforcement authorities — is a positive step for people who have been affected by

HDMA expands government affairs team

HDMA expands government affairs team

ARLINGTON, Va. — Ruth Miller has joined the government affairs team of the Healthcare Distribution Management Association (HDMA). HDMA said Monday that Miller has been named senior director of regulatory affairs, a new position. She will be responsible for recommending policies and positions on federal regulatory proposals, focusing with a primarily on proposals related to

Obama signs Patient Access and Effective Drug Enforcement Act

Obama signs Patient Access and Effective Drug Enforcement Act

ARLINGTON, Va. — Pharmacy industry groups hailed the president’s approval of key legislation to help combat abuse and misuse of prescription drugs. President Barack Obama on Tuesday signed into law the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 (S. 483), which had drawn strong support from the National Association of Chain Drug

Prescription drug abuse bill ready to be signed into law

Prescription drug abuse bill ready to be signed into law

ARLINGTON, Va. — Legislation that would improve efforts to fight prescription drug abuse without impeding legitimate patients’ access to medication is set to go before President Barack Obama to be signed into law. The House of Representatives on Tuesday passed the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 (S. 483) in the

Senate OK’s key drug abuse legislation

Senate OK’s key drug abuse legislation

ARLINGTON, Va. — The U.S. Senate has passed the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 (S. 483), which is seen as striking a balance between fighting drug abuse and upholding legitimate drug use. The National Association of Chain Drug Stores, which supports the bill, said Friday that the measure would advance

HDMA honors AmerisourceBergen for DSCSA effort

HDMA honors AmerisourceBergen for DSCSA effort

ARLINGTON, Va. — AmerisourceBergen Corp. was among the winners of the 2016 Distribution Management Award from the Healthcare Distribution Management Association (HDMA). HDMA said Tuesday that AmerisourceBergen received recognition for centralizing its data for Drug Supply Chain Security Act (DSCSA) compliance and preparing for long-term serialization requirements. The award was presented at the HDMA 2016

Rx takes hard look at long-awaited Medicaid AMP rule

Rx takes hard look at long-awaited Medicaid AMP rule

ARLINGTON, Va. — The National Association of Chain Drug Stores was working with member companies at presstime to review the final rule on Medicaid prescription reimbursements. The Centers for Medicare & Medicaid Services (CMS) says the 658-page rule — which takes effect April 1 after a comment period — establishes a regulatory definition for average

Scherr, Giacomin to lead HDMA board

Scherr, Giacomin to lead HDMA board

ARLINGTON, Va. —  Ted Scherr, president and chief executive officer of Dakota Drug Inc., has been re-elected as chairman of the Healthcare Distribution Management Association (HDMA). HDMA said Tuesday that Jon Giacomin, CEO of the pharmaceutical segment at Cardinal Health Inc., also has been re-elected as vice chairman. The elections were made at the sixth

HDMA honors McKesson’s Julian with Nexus Award

HDMA honors McKesson’s Julian with Nexus Award

ARLINGTON, Va. — McKesson Corp. executive Paul Julian has received the 2015 Nexus Award for Lifetime Achievement from the Healthcare Distribution Management Association’s Center for Healthcare Supply Chain Research and Genentech Inc. HDMA said Tuesday that Julian, executive vice president and group president at McKesson, was presented the award this week at the 2015 HDMA

Drug distributors reap benefits of tech investment

Drug distributors reap benefits of tech investment

  ARLINGTON, Va. — The rapid adoption of new technology is making the drug distribution industry healthier than ever. The sector’s investment in new systems and ability to quickly get them up and running is giving it unsurpassed accuracy and efficiency, said John Gray, president and chief executive officer of the Healthcare Distribution Management Association

H.D. Smith tabbed as HDMA award finalist for mobile ordering system

SPRINGFIELD, Ill. — H.D. Smith was named as a finalist for the Healthcare Distribution Management Association’s (HDMA) Distribution Management Award for its mobile controlled substance ordering system (CSOS). The pharmaceutical distributor said Tuesday that the mobile CSOS is the first of its kind offered by a U.S. wholesaler and is set to be rolled out

HDMA lauds FDA drug tracing guidelines

WASHINGTON — The Healthcare Distribution Management Association (HDMA) is praising the Food and Drug Administration for its flexibility pertaining to new product tracing rules, specifically on the FDA’s recently released guidance titled “Product Tracing Requirements — Compliance Policy.” The association had sent letters to the regulatory agency in November and then again last month in